Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: A randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk

Huei Ming Liu, Anushka Patel, Alex Brown, Sandra Eades, Noel Hayman, Stephen Jan, Ian Ring, Greg Stewart, Andrew Tonkin, Tarun Weeramanthri, Victoria Wade, A Rodgers, Tim Usherwood, Bruce Neal, David Peiris, Hugh Burke, Christopher Reid, Alan Cass

    Research output: Contribution to journalArticle

    30 Citations (Scopus)

    Abstract

    Background. The Kanyini Guidelines Adherence with the Polypill (Kanyini-GAP) Study aims to examine whether a polypill-based strategy (using a single capsule containing aspirin, a statin and two blood pressure-lowering agents) amongst Indigenous and non-Indigenous people at high risk of experiencing a cardiovascular event will improve adherence to guideline-indicated therapies, and lower blood pressure and cholesterol levels. Methods/Design. The study is an open, randomised, controlled, multi-centre trial involving 1000 participants at high risk of cardiovascular events recruited from mainstream general practices and Aboriginal Medical Services, followed for an average of 18 months. The participants will be randomised to one of two versions of the polypill, the version chosen by the treating health professional according to clinical features of the patient, or to usual care. The primary study outcomes will be changes, from baseline measures, in serum cholesterol and systolic blood pressure and self-reported current use of aspirin, a statin and at least two blood pressure lowering agents. Secondary study outcomes include cardiovascular events, renal outcomes, self-reported barriers to indicated therapy, prescription of indicated therapy, occurrence of serious adverse events and changes in quality-of-life. The trial will be supplemented by formal economic and process evaluations. Discussion. The Kanyini-GAP trial will provide new evidence as to whether or not a polypill-based strategy improves adherence to effective cardiovascular medications amongst individuals in whom these treatments are indicated.

    Original languageEnglish
    Article number458
    Number of pages8
    JournalBMC Public Health
    Volume10
    Issue number458
    DOIs
    Publication statusPublished - 2010

    Fingerprint Dive into the research topics of 'Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: A randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk'. Together they form a unique fingerprint.

  • Cite this

    Liu, H. M., Patel, A., Brown, A., Eades, S., Hayman, N., Jan, S., Ring, I., Stewart, G., Tonkin, A., Weeramanthri, T., Wade, V., Rodgers, A., Usherwood, T., Neal, B., Peiris, D., Burke, H., Reid, C., & Cass, A. (2010). Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: A randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk. BMC Public Health, 10(458), [458]. https://doi.org/10.1186/1471-2458-10-458